Cargando…
Aggressive Perioperative Management for Immune Thrombocytopenic Purpura in a Patient Undergoing Open Heart Surgery: A Correct Strategy in an Emergent Patient?
Immune thrombocytopenic purpura (ITP) is an autoimmune pathology that causes thrombocytopenia. This can become extremely troublesome when dealing with the rare clinical scenario of having to operate a highly invasive procedure on patients with thrombocytopenia. We report a case of a 66-year-old male...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8553294/ https://www.ncbi.nlm.nih.gov/pubmed/34725582 http://dx.doi.org/10.7759/cureus.18310 |
_version_ | 1784591548599500800 |
---|---|
author | Mallick, Hamdan Siddiqui, Sobia T Khan, Yasir Ahmad, Ismael Shahabuddin, Syed |
author_facet | Mallick, Hamdan Siddiqui, Sobia T Khan, Yasir Ahmad, Ismael Shahabuddin, Syed |
author_sort | Mallick, Hamdan |
collection | PubMed |
description | Immune thrombocytopenic purpura (ITP) is an autoimmune pathology that causes thrombocytopenia. This can become extremely troublesome when dealing with the rare clinical scenario of having to operate a highly invasive procedure on patients with thrombocytopenia. We report a case of a 66-year-old male with multiple comorbidities, including ITP, who underwent coronary artery bypass grafting (CABG) with an aortic valve replacement (AVR). He deteriorated rapidly, prompting urgent procedures. Little to no literature exists on the treatment plan for a critical patient with ITP who is about to undergo an open heart surgery. Our goal was to aggressively treat the patient with prednisolone, azathioprine, and platelets in the short preoperative time in order to maximize the prognosis. Our patient remained stable postoperatively, developed no complications, and was discharged successfully. |
format | Online Article Text |
id | pubmed-8553294 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Cureus |
record_format | MEDLINE/PubMed |
spelling | pubmed-85532942021-10-31 Aggressive Perioperative Management for Immune Thrombocytopenic Purpura in a Patient Undergoing Open Heart Surgery: A Correct Strategy in an Emergent Patient? Mallick, Hamdan Siddiqui, Sobia T Khan, Yasir Ahmad, Ismael Shahabuddin, Syed Cureus Cardiac/Thoracic/Vascular Surgery Immune thrombocytopenic purpura (ITP) is an autoimmune pathology that causes thrombocytopenia. This can become extremely troublesome when dealing with the rare clinical scenario of having to operate a highly invasive procedure on patients with thrombocytopenia. We report a case of a 66-year-old male with multiple comorbidities, including ITP, who underwent coronary artery bypass grafting (CABG) with an aortic valve replacement (AVR). He deteriorated rapidly, prompting urgent procedures. Little to no literature exists on the treatment plan for a critical patient with ITP who is about to undergo an open heart surgery. Our goal was to aggressively treat the patient with prednisolone, azathioprine, and platelets in the short preoperative time in order to maximize the prognosis. Our patient remained stable postoperatively, developed no complications, and was discharged successfully. Cureus 2021-09-27 /pmc/articles/PMC8553294/ /pubmed/34725582 http://dx.doi.org/10.7759/cureus.18310 Text en Copyright © 2021, Mallick et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Cardiac/Thoracic/Vascular Surgery Mallick, Hamdan Siddiqui, Sobia T Khan, Yasir Ahmad, Ismael Shahabuddin, Syed Aggressive Perioperative Management for Immune Thrombocytopenic Purpura in a Patient Undergoing Open Heart Surgery: A Correct Strategy in an Emergent Patient? |
title | Aggressive Perioperative Management for Immune Thrombocytopenic Purpura in a Patient Undergoing Open Heart Surgery: A Correct Strategy in an Emergent Patient? |
title_full | Aggressive Perioperative Management for Immune Thrombocytopenic Purpura in a Patient Undergoing Open Heart Surgery: A Correct Strategy in an Emergent Patient? |
title_fullStr | Aggressive Perioperative Management for Immune Thrombocytopenic Purpura in a Patient Undergoing Open Heart Surgery: A Correct Strategy in an Emergent Patient? |
title_full_unstemmed | Aggressive Perioperative Management for Immune Thrombocytopenic Purpura in a Patient Undergoing Open Heart Surgery: A Correct Strategy in an Emergent Patient? |
title_short | Aggressive Perioperative Management for Immune Thrombocytopenic Purpura in a Patient Undergoing Open Heart Surgery: A Correct Strategy in an Emergent Patient? |
title_sort | aggressive perioperative management for immune thrombocytopenic purpura in a patient undergoing open heart surgery: a correct strategy in an emergent patient? |
topic | Cardiac/Thoracic/Vascular Surgery |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8553294/ https://www.ncbi.nlm.nih.gov/pubmed/34725582 http://dx.doi.org/10.7759/cureus.18310 |
work_keys_str_mv | AT mallickhamdan aggressiveperioperativemanagementforimmunethrombocytopenicpurpurainapatientundergoingopenheartsurgeryacorrectstrategyinanemergentpatient AT siddiquisobiat aggressiveperioperativemanagementforimmunethrombocytopenicpurpurainapatientundergoingopenheartsurgeryacorrectstrategyinanemergentpatient AT khanyasir aggressiveperioperativemanagementforimmunethrombocytopenicpurpurainapatientundergoingopenheartsurgeryacorrectstrategyinanemergentpatient AT ahmadismael aggressiveperioperativemanagementforimmunethrombocytopenicpurpurainapatientundergoingopenheartsurgeryacorrectstrategyinanemergentpatient AT shahabuddinsyed aggressiveperioperativemanagementforimmunethrombocytopenicpurpurainapatientundergoingopenheartsurgeryacorrectstrategyinanemergentpatient |